/
/
/

Aurobindo Pharma Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)1,784.30
Volume (₹)1.84 L
High (₹)1,805.00
Upper Circuit1,963.50
Low (₹)1,776.00
Lower Circuit1,606.50
Prev Close1,785.00
52W High (₹)1,805.00
Price1,789.00
52W Low (₹)1,106.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)102895.00 Cr
Div. Yield (%)0.22
PE Ratio25.79
Debt to Equity0.20
Price to Book2.00
Book Value652.39
EPS (TTM)69.35
Face Value1.00
ROE (%)9.93

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
LTP
1W Low
1W High
Market cap (₹)
1838.4+60.7 (3.41%)
1722
1839.70
4,37,963Cr
10170.5+390.5 (3.99%)
9863
10181.50
2,69,451Cr
4733+119.6 (2.59%)
4553
4753.40
1,79,456Cr
2323.1-82.4 (-3.43%)
2252.40
2441.90
1,26,703Cr
1199.7-45.8 (-3.68%)
1172
1266.60
1,19,341Cr
1366.5+14.5 (1.07%)
1336.70
1384
1,13,664Cr
1392.9+14 (1.02%)
1364.60
1408
1,13,246Cr
2508.9+16.1 (0.65%)
2457.90
2561.20
1,03,881Cr
1789+107.6 (6.40%)
1656.20
1805
1,02,895Cr
1979.4-31.6 (-1.57%)
1944.10
2062.10
90,887Cr

Key Highlights of Aurobindo Pharma Ltd Balance Sheet

Aurobindo Pharma Ltd balance sheet discloses shareholders' funds of ₹58.08Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹58.08Cr, and the reserves and surplus of the company is ₹22659.6Cr.

The company has its non-current liabilities with total liabilities of ₹34416.9Cr as of 2026-03-31.

The current liabilities are ₹6992.44Cr as of 2026-03-31. At the same time, current assets are ₹8714.97Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹16836.2Cr and tangible assets of ₹2543.73Cr, provided in the Aurobindo Pharma Ltd financial statements.